HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis of Fijiolide A via an Atropselective Paracyclophane Formation.

Abstract
Fijiolide A is a secondary metabolite isolated from a marine-derived actinomycete and displays inhibitory activity against TNF-α-induced activation of NFκB, an important transcription factor and a potential target for the treatment of different cancers and inflammation related diseases. Fijiolide A is a glycosylated complex paracyclophane, which is structurally closely related to the Bergman-aromatization product of enediyne C-1027. We report an enantioselective synthesis of fijiolide A demonstrating the power of fully intermolecular ruthenium-catalyzed [2 + 2 + 2]-cyclotrimerizations with three different alkynes to assemble the heavily substituted central arene core. The characteristic strained [2.6]paracyclophane structure is accessed by a templated atropselective macroetherification reaction.
AuthorsChristoph Heinz, Nicolai Cramer
JournalJournal of the American Chemical Society (J Am Chem Soc) Vol. 137 Issue 35 Pg. 11278-81 (Sep 09 2015) ISSN: 1520-5126 [Electronic] United States
PMID26301726 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: